Bliss GVS Pharma 

₹273
12
+₹9.89+3.76% 今天

統計

當日最高
276.39
當日最低
264.1
52週高點
273.4
52週低點
112.07
成交量
1,809,355
平均成交量
-
市值
28.84B
本益比
24.94
股息殖利率
0.19%
股息
0.52

即將到來

股息

0.19%股息殖利率
Feb 26
₹0.5
Aug 25
₹0.5
Aug 24
₹0.5
Jul 23
₹0.5
Jul 22
₹0.5
10年成長
7.18%
5年成長
14.87%
3年成長
25.99%
1年成長
100%

財報

28Jan預期
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

10.51%利潤率
有盈利
2019
2020
2021
2022
2023
2024
16.04B營收
1.69B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BLISSGVS.NSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Show more...
執行長
Mr. Shibroor Narsimha Kamath
員工
966
國家
印度
ISIN
INE416D01022

上市

0 Comments

分享你的想法

FAQ

Bliss GVS Pharma 今天的股價是多少?
BLISSGVS.NSE 目前價格為 ₹273 INR,過去 24 小時上漲了 +3.76%。在圖表上更密切關注 Bliss GVS Pharma 股價表現。
Bliss GVS Pharma 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Bliss GVS Pharma 的股票以代號 BLISSGVS.NSE 進行交易。
Bliss GVS Pharma 的股價在上漲嗎?
BLISSGVS.NSE 股票較上週上漲 +7.86%,本月上漲 +25.24%,過去一年 Bliss GVS Pharma 上漲 +123.77%。
Bliss GVS Pharma 的市值是多少?
今天 Bliss GVS Pharma 的市值為 28.84B
Bliss GVS Pharma 去年的營收是多少?
Bliss GVS Pharma 去年的營收為 16.04BINR。
Bliss GVS Pharma 去年的淨利是多少?
BLISSGVS.NSE 去年的淨收益為 1.69BINR。
Bliss GVS Pharma 會發放股息嗎?
是的,BLISSGVS.NSE 的股息每 半年一次 發放一次。每股最新股息為 0.5 INR。截至今日,股息殖利率(FWD)% 為 0.19%。
Bliss GVS Pharma 有多少名員工?
截至 April 27, 2026,公司共有 966 名員工。
Bliss GVS Pharma 位於哪個產業?
Bliss GVS Pharma從事於Health & Wellness產業。
Bliss GVS Pharma 何時完成拆股?
Bliss GVS Pharma 上次拆股發生於 September 26, 2008,比例為 8:5。
Bliss GVS Pharma 的總部在哪裡?
Bliss GVS Pharma 的總部位於 印度 的 Mumbai。